SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants sharp rally is being attributed by traders to a reported partnership with The Clearing House around interoperability for tokenized bank deposits, alongside expectations of institutional adoption. Bulls emphasize QNTs limited supply, while skeptics question how directly the development benefits the token and warn the rapid run may invite profit-taking.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Attention centers on Panasonic Advanced Technologys announced Jasmy/JANCTION Smart Render collaboration, which traders say has demonstrated faster rendering through distributed GPUs and is moving toward commercial use. Bulls see it as evidence of real development, while skeptics question whether the product will create direct demand for JASMY and view the price move as speculative.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CROs weak price action is fueling persistent concern about token-supply dilution, including the return of previously burned coins, and criticism of Crypto.coms management. Some traders see potential catalysts in the Cronos app and roadmap or speculate about an ETF, but that optimism is tempered by skepticism and the ETF talk remains unconfirmed.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuums finalized $100 million CHIPS Act R&D award is drawing attention, with traders viewing federal backing and plans to expand U.S. quantum-manufacturing capabilities as validation of its growth prospects. The bullish reaction is tempered by concerns about the companys high valuation relative to current revenue and volatile trading.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

CMSs ACA anti-fraud crackdown and cancellation of roughly 315,000 enrollments are driving concern, with traders highlighting Oscars expected retroactive disenrollment of 250,000300,000 members and possible effects on growth. Some view the cancellations as removal of fraudulent ghost policies and say the impact is reflected in guidance, while others worry about membership and policy risks.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

Discussion centers on Bankrs expanding AI-agent and on-chain trading infrastructure, with traders highlighting integrations across ecosystems and fee-generating activity as support for a utility-driven thesis. Sentiment is largely bullish, but some question whether adoption justifies the valuation and warn that the sharp moves could be speculative or short-lived.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is drawing attention after a sharp, high-volume price move, which bullish traders link to discussion of Flexas European expansion and broader payment-network development. Skeptics see another short-lived pump and question whether real adoption will translate into demand for the token.

ERock, Inc. operates, designs, and installs distributed generation power systems. The firm primarily serves data centers, utilities, commercial and industrial businesses. The company was founded on 2006 and is headquartered in Houston, TX.

ERock Inc. - Ordinary Shares - Class A

EROC is drawing attention for its Anthropic power-system order and expanding backlog, reinforcing its role as a natural-gas, on-site power provider for AI data centers facing grid constraints. Bulls compare it with Bloom Energy and point to high short interest, while skeptics question profitability, execution, and the companys post-IPO volatility.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

MUU is drawing attention as a leveraged play on Microns sharp swings, with traders focused on technical levels and short-term momentum rather than a new company-specific catalyst. Some are chasing call-option activity and looking for further upside, while others warn that crowded, short-dated bets and choppy trading make the ETF especially volatile.

Aventus Network

AVT is drawing attention for volatile moves in a thinly traded, low-float token, with traders speculating about a squeeze while others question whether buying volume can overcome persistent selling. The community also points to Aventuss disclosure that an attacker exploited a code vulnerability and sold minted AVT into the market as the cause of a sharp selloff, alongside ongoing concerns about token supply and liquidity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Short Interest in Jyong Biotech Ltd. (NASDAQ:MENS) Decreases By 43.2%

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a significant decline in short interest in April. As of April 15th, there was short interest totaling 133,023 shares, a decline of 43.2% from...

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Significant Decrease in Short Interest

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) was the target of a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 234,254 shares, a...

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) was the target of a significant drop in short interest in March. As of March 13th, there was short interest totaling 288,865 shares, a drop of 22.7...

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Large Decrease in Short Interest

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 373,692 shares, a drop of 19.5...

Jyong Biotech (NASDAQ:MENS) Stock Price Down 12.3% - Time to Sell?

Jyong Biotech (NASDAQ:MENS) Shares Down 12.3% - Here's Why...

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Update

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 649,057 shares, an...

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a significant increase in short interest in December. As of December 15th, there was short interest totaling 252,374 shares, an increase of...

Jyong Biotech (NASDAQ:MENS) Shares Gap Up - Still a Buy?

Jyong Biotech (NASDAQ:MENS) Shares Gap Up - Time to Buy...

Jyong Biotech (NASDAQ:MENS) Stock Price Down 19.3% - Here's What Happened

Jyong Biotech (NASDAQ:MENS) Shares Down 19.3% - Should You Sell...

Jyong Biotech (NASDAQ:MENS) Trading Down 5.9% - Here's Why

Jyong Biotech (NASDAQ:MENS) Shares Down 5.9% - Here's Why...

Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. It offers plant-derived drugs that focus on the treatment of urinary system diseases. The company was founded by Fu Feng Kuo in July 2002 and is headquartered in New Taipei, Taiwan.

Jyong Biotech Ltd.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.03
Prev Close	$2.15
Open	$2.27
Dividend Yield	0.00%
50-Day Moving Average	$2.19
Beta	4.54
Avg. Volume	35,091.40
PE Ratio	-31.97

52-Week High	$63.00
52-Week Low	$1.43
Market Capitalization	$150.69M
EPS (Annual)	-$0.064
Price to Book	-6.05
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MENS Fundamentals